What can blood biomarkers tell us about cardiovascular risk in obstructive sleep apnea?

Sleep and Breathing

Volumn 19, Issue 3, 2015, Pages 755-768

  de Araújo Freitas, Ivan Guerra ^a   de Bruin, Pedro Felipe Carvalhedo ^a   Bittencourt, Lia ^b   de Bruin, Veralice Meireles Sales ^a   Tufik, Sérgio ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biomarkers; Obstructive sleep apnea; Pathophysiology

Indexed keywords

8 ISOPROSTANE; ADIPOCYTOKINE; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYSTEINE; FATTY ACID; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN A1C; HOMOCYSTEINE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

BLOOD; CARDIOVASCULAR RISK; CLINICAL PRACTICE; ENVIRONMENTAL EXPOSURE; HEART FAILURE; HEART MUSCLE TENSION; HEREDITY; HUMAN; OBESITY; PATHOPHYSIOLOGY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; REVIEW; SLEEP DISORDERED BREATHING; CARDIOVASCULAR DISEASES; COMPLICATION; RISK FACTOR; SLEEP APNEA, OBSTRUCTIVE; STATISTICS;

BIOMARKERS; CARDIOVASCULAR DISEASES; HUMANS; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC;

EID: 84940961904     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-015-1143-9     Document Type: Review

References (103)

1. May A, Wang TJ (2008) Biomarkers for cardiovascular disease: challenges and future directions. Trends Mol Med 14(6):261–267
2. Shamsuzzaman AS, Gersh BJ, Somers VK (2003) Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290(14):1906–1914
3. Lurie A (2011) Cardiovascular disorders associated with obstructive sleep apnea. Adv Cardiol 46:197–266
4. Kostapanos MS, Elisaf MS, Mikhailidis DP (2012) Obstructive sleep apnea and cardiovascular risk: is metabolic syndrome the link? Angiology 63(8):569–573
5. Kuniyoshi FH, Pusalavidyasagar S, Singh P, Somers VK (2010) Cardiovascular consequences of obstructive sleep apnoea. Indian J Med Res 131:196–205
6. Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, Shamsuzzaman AS, Somers VK (2003) Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 107(20):2589–2594
7. Monahan K, Storfer-Isser A, Mehra R, Shahar E, Mittleman M, Rottman J, Punjabi N, Sanders M, Quan SF, Resnick H, Redline S (2009) Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol 54(19):1797–1804
8. Namtvedt SK, Randby A, Einvik G, Hrubos-Strom H, Somers VK, Rosjo H, Omland T (2011) Cardiac arrhythmias in obstructive sleep apnea (from the Akershus sleep apnea project). Am J Cardiol 108(8):1141–1146
9. Kasai T, Bradley TD (2011) Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 57(2):119–127
10. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V (2005) Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353(19):2034–2041
11. Sorajja D, Gami AS, Somers VK, Behrenbeck TR, Garcia-Touchard A, Lopez-Jimenez F (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133(4):927–933
12. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342(19):1378–1384
13. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ (2002) Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359(9302):204–210
14. Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140(2):534–542
15. Kent BD, Ryan S, McNicholas WT (2011) Obstructive sleep apnea and inflammation: relationship to cardiovascular co-morbidity. Respir Physiol Neurobiol 178(3):475–481
16. Montemurro LT, Floras JS, Picton P, Kasai T, Alshaer H, Gabriel JM, Bradley TD (2014) Relationship of heart rate variability to sleepiness in patients with obstructive sleep apnea with and without heart failure. J Clin Sleep Med 10(3):271–276
17. Yumino D, Kasai T, Kimmerly D, Amirthalingam V, Floras JS, Bradley TD (2013) Differing effects of obstructive and central sleep apneas on stroke volume in patients with heart failure. Am J Respir Crit Care Med 187(4):433–438
18. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AL (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32(4):447–470
19. Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL Jr (2008) Biology of the natriuretic peptides. Am J Cardiol 101(3A):3–8
20. Hildebrandt P, Collinson PO (2008) Amino-terminal pro-B-type natriuretic peptide testing to assist the diagnostic evaluation of heart failure in symptomatic primary care patients. Am J Cardiol 101(3A):25–28
21. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355(9210):1126–1130
22. Baggish AL, van Kimmenade RR, Januzzi JL Jr (2008) The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide level. Am J Cardiol 101(3A):43–48
23. Ordonez-Llanos J, Collinson PO, Christenson RH (2008) Amino-terminal pro-B-type natriuretic peptide: analytic considerations. Am J Cardiol 101(3A):9–15
24. Rao A, Georgiadou P, Francis DP, Johnson A, Kremastinos DT, Simonds AK, Coats AJ, Cowley A, Morrell MJ (2006) Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. J Sleep Res 15(1):81–88
25. Sin DD, Logan AG, Fitzgerald FS, Liu PP, Bradley TD (2000) Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne–Stokes respiration. Circulation 102(1):61–66
26. Kita H, Ohi M, Chin K, Noguchi T, Otsuka N, Tsuboi T, Itoh H, Nakao K, Kuno K (1998) The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure. J Sleep Res 7(3):199–207
27. Koga S, Ikeda S, Urata J, Kohno S (2008) Effect of nasal continuous positive airway pressure in men on global left ventricular myocardial performance in patients with obstructive sleep apnea syndrome. Am J Cardiol 101(12):1796–1800
28. Ljunggren M, Lindahl B, Theorell-Haglöw J, Linberg E (2012) Association between sleep apnea and elevated levels of type B natriuretic peptide in a community-based sample of women. Sleep 35(11):1521–1527
29. Tasci S, Manka R, Scholtyssek S, Lentini S, Troatz C, Stoffel-Wagner B, Lüderitz B (2006) NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure. Clin Res Cardiol 95(1):23–30
30. Sanchez A, Schwartz AR, Sanchez PL, Fernandez JL, Ramos J, Martin-Herrero F, González-Celador R, Ruano R, Bregón I, Martín-Luengo C, Gómez FP (2008) Hemodynamic and inflammatory markers of sleep apnea–hypopnea syndrome and nocturnal hypoxemia: effects of treatment with nasal continuous positive airway pressure. Arch Bronconeumol 44(10):531–539
31. Moller DS, Lind P, Strunge B, Pedersen EB (2003) Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16(4):274–280
32. Svatikova A, Shamsuzzaman AS, Wolk R, Phillips BG, Olson LJ, Somers VK (2004) Plasma brain natriuretic peptide in obstructive sleep apnea. Am J Cardiol 94(4):529–3
33. Colish J, Walker JR, Elmayergi N, Almutairi S, Alharbi F, Lytwyn M, Francis A, Bohonis S, Zeglinski M, Kirkpatrick ID, Sharma S, Jassal DS (2012) Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI. Chest 141(3):674–681
34. Patwardhan AA, Larson MG, Levy D, Benjamin EJ, Leip EP, Keyes MJ, Wang TJ, Gottlieb DJ, Vasan RS (2006) Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep 29(10):1301–1306
35. Querejeta Roca G, Redline S, Punjabi N, Claggett B, Ballantyne CM, Solomon SD, Shah AM (2013) Sleep apnea is associated with subclinical myocardial injury in the community. The ARIC-SHHS study. Am J Respir Crit Care Med 188(12):1460–1465
36. Vartany E, Imevbore M, O’Malley M, Manfredi C, Pasquarella C, Scinto L, Fine J (2006) N-terminal pro-brain natriuretic peptide for detection of cardiovascular stress in patients with obstructive sleep apnea syndrome. J Sleep Res 15(4):424–429
37. Hubner RH, El Mokhtari NE, Freitag S, Rausche T, Goder R, Tiroke A, Lins M, Simon R, Bewig B (2008) NT-proBNP is not elevated in patients with obstructive sleep apnoea. Respir Med 102(1):134–142
38. Cifci N, Uyar M, Elbek O, Suyur H, Ekinci E (2010) Impact of CPAP treatment on cardiac biomarkers and pro-BNP in obstructive sleep apnea syndrome. Sleep Breath 14(3):241–244
39. Sans Capdevila O, Crabtree VM, Kheirandish-Gozal L, Gozal D (2008) Increased morning brain natriuretic peptide levels in children with nocturnal enuresis and sleep-disordered breathing: a community-based study. Pediatrics 121(5):e1208–e1214
40. Kaditis AG, Chaidas K, Alexopoulos EI, Varlami V, Malakasioti G, Gourgoulianis K (2011) Effects of adenotonsillectomy on R–R interval and brain natriuretic peptide levels in children with sleep apnea: a preliminary report. Sleep Med 12(7):646–651
41. Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5(2):136–143
42. Pivovarova O, Gogebakan O, Kloting N, Sparwasser A, Weickert MO, Haddad I, Nikiforova VJ, Bergmann A, Kruse M, Seltmann AC, Blüher M, Pfeiffer AFH, Rudovich N (2012) Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity? J Clin Endocrinol Metab 97(5):E731–E739
43. Dessi-Fulgheri P, Sarzani R, Tamburrini P, Moraca A, Espinosa E, Cola G, Giantomassi L, Rappelli A (1997) Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients. J Hypertens 15(12 Pt 2):1695–1699
44. Naughton MT, Rahman MA, Hara K, Floras JS, Bradley TD (1995) Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation 91(6):1725–1731
45. Dries DL, Stevenson LW (2000) Brain natriuretic peptide as bridge to therapy for heart failure. Lancet 355(9210):1112–1113
46. Malhotra A, Hillman D (2008) Obesity and the lung: 3. Obesity, respiration and intensive care. Thorax 63(10):925–931
47. Tanaka A, Shimada K, Sano T, Namba M, Sakamoto T, Nishida Y, Kawarabayashi T, Fukuda D, Yoshikawa J (2005) Multiple plaque rupture and C-reactive protein in acute myocardial infarction. J Am Coll Cardiol 45(10):1594–1599
48. Pepys MB, Hirschfield GM (2003) C-reactive protein: a critical update. J Clin Investig 111(12):1805–1812
49. Pasceri V, Cheng JS, Willerson JT, Yeh ET (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103(21):2531–2534
50. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46(5):801–809
51. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105(21):2462–2464
52. Shearer WT, Reuben JM, Mullington JM, Price NJ, Lee BN, Smith EO, Szuba MP, Van Dongen HP, Dinges DF (2001) Soluble TNF-alpha receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol 107(1):165–170
53. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107(8):1129–1134
54. Mills PJ, Natarajan L, von Kanel R, Ancoli-Israel S, Dimsdale JE (2009) Diurnal variability of C-reactive protein in obstructive sleep apnea. Sleep Breath 13(4):415–420
55. Guven SF, Turkanni MH, Ciftci B, Ciftci TU, Erdogan Y (2012) The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath 16(1):217–221
56. Bhushan B, Guleria R, Misra A, Pandey RM, Luthra K, Vikram NK (2009) Obstructive sleep apnoea correlates with C-reactive protein in obese Asian Indians. Nutr Metab Cardiovasc Dis 19(3):184–189
57. Mermigkis C, Bouloukaki I, Mermigkis D, Kallergis E, Mavroudi E, Varouchakis G, Tzortzaki E, Siafakas N, Schiza SE (2012) CRP evolution pattern in CPAP-treated obstructive sleep apnea patients. Does gender play a role? Sleep Breath 16(3):813–819
58. Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27(8):1507–1511
59. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP) — no association with sleep duration or sleep disordered breathing. Sleep 30(8):991–996
60. Ciftci TU, Kokturk O, Bukan N, Bilgihan A (2004) The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28(2):87–91
61. Steiropoulus P, Papanas N, Nena E, Antoniadou M, Serasli E, Papoti S, Hatzizisi O, Kyriazis G, Tzouvelekis A, Maltezos E, Tsara V, Bouros D (2010) Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediat Inflamm 2010:675320. doi:10.1155/2010/675320
62. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 82(5):1313–1316
63. Imagawa S, Yamaguchi Y, Ogawa K, Obara N, Suzuki N, Yamamoto M, Nagasawa T (2004) Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea–hypopnea syndrome. Respiration 71(1):24–29
64. Mehra R, Storfer-Isser A, Kirchner HL, Johnson N, Jenny N, Tracy RP, Redline S (2006) Soluble interleukin 6 receptor: a novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med 166(16):1725–1731
65. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM, Palma-Reis FJ, Boers GH, Sheahan RG, Israelsson B, Uiterwaal CS, Meleady R, McMaster D, Verhoef P, Witteman J et al (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 277(22):1775–1781
66. Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2006) Serum homocysteine levels and cardiovascular morbidity in obstructive sleep apnea syndrome. Respir Med 100(3):536–541
67. Lavie L, Perelman A, Lavie P (2001) Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest 120(3):900–908
68. Steiropoulos P, Tsara V, Nena E, Fitili C, Kataropoulou M, Froudarakis M, Christaki P, Bourus D (2007) Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea–hypopnea syndrome. Chest 132(3):843–851
69. Ozkan Y, Ozkan E, Simsek B (2002) Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 82(3):269–277
70. Cintra F, Tufik S, D’Almeida V, Calegare BF, de Paola A, Oliveira W, Rizzi C, Roizenblatt S, Poyares D (2011) Cysteine: a potential biomarker for obstructive sleep apnea. Chest 139(2):246–252
71. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T (2006) Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 64(1):12–19
72. Duarte FH, Jallad RS, Amaro AC, Drager LF, Lorenzi-Filho G, Bronstein MD (2013) The impact of sleep apnea treatment on carbohydrate metabolism in patients with acromegaly. Pituitary 16(3):341–350
73. Cavalcante AG, de Bruin PF (2009) The role of oxidative stress in COPD: current concepts and perspectives. J Bras Pneumol 35(12):1227–1237
74. Karamanli H, Ozol D, Ugur KS, Yildirim Z, Armutçu F, Bozkurt B, Yigitoglu R (2014) Influence of CPAP treatment on airway and systemic inflammation in OSAS patients. Sleep Breath 18(2):251–256
75. Lee DH, Ha MH, Kim JH, Christiani DC, Gross MD, Steffes M, Blomhoff R, Jacobs DR Jr (2003) Gamma-glutamyltransferase and diabetes—a 4 year follow-up study. Diabetologia 46(3):359–364
76. Stojakovic T, Scharnagl H, Trauner M, Pieske B, Wellnitz B, Seelhorst U, Schilling D, Winkelmann BR, Boehm BO, März W (2010) Serum gamma-glutamyl transferase and mortality in persons undergoing coronary angiography—the Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis 208(2):564–571
77. Paolicchi A, Emdin M, Passino C, Lorenzini E, Titta F, Marchi S, Malvaldi G, Pompella A (2006) Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 186(1):80–85
78. Paolicchi A, Emdin M, Ghliozeni E, Ciancia E, Passino C, Popoff G, Pompella A (2004) Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 109(11):1440
79. Kanbay A, Kaya E, Buyukoglan H, Ozdogan N, Kaya MG, Oymak FS, Gulmez I, Demir R, Kokturk O (2011) Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Respir Med 105(4):637–642
80. Gude F, Rey-Garcia J, Fernandez-Merino C, Meijide L, Garcia-Ortiz L, Zamarron C, Gonzalez-Quintela A (2009) Serum levels of gamma-glutamyl transferase are associated with markers of nocturnal hypoxemia in a general adult population. Clin Chim Acta 407(1–2):67–71
81. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ (2004) Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19(12):1175–1180
82. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N (2004) Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 141(6):413–420
83. Papanas N, Steiropoulos P, Nena E, Tzouvelekis A, Maltezos E, Trakada G, Bouros D (2009) HbA1c is associated with severity of obstructive sleep apnea hypopnea syndrome in nondiabetic men. Vasc Health Risk Manag 5:751–756
84. Sökücü SN, Karasulu L, Dalar L, Ozdemir C, Seyhan EC, Aydin S, Altin S (2013) Effect of hypoxia on glucose metabolism in nondiabetic patients with obstructive sleep apnea syndrome. Arch Bronconeumol 49(8):321–325
85. Cizza G, Piaggi P, Lucassen EA, de Jonge L, Walter M, Mattingly MS, Kalish H, Csako G, Rother KI (2013) Obstructive sleep apnea is a predictor of abnormal glucose metabolism in chronically sleep deprived obese adults. PLos ONE 8(5):e65400
86. Iftikhar IH, Blankfield RP (2012) Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis. Lung 190(6):605–611
87. Trujillo ME, Scherer PE (2006) Adipose tissue-derived factors: impact on health and disease. Endocr Rev 27(7):762–778
88. Northcott JM, Yeganeh A, Taylor CG, Zahradka P, Wigle JT (2012) Adipokines and the cardiovascular system: mechanisms mediating health and disease. Can J Physiol Pharmacol 90(8):1029–1059
89. Mattu HS, Randeva HS (2013) Role of adipokines in cardiovascular disease. J Endocrinol 216(1):T17–T36
90. Ip MS, Lam KS, Ho C, Tsang KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118(3):580–586
91. Verma S, Li SH, Wang CH, Fedak PW, Li RK, Weisel RD, Mickle DA (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108(6):736–740
92. Yamamoto Y, Fujiuchi S, Hiramatsu M, Nishigaki Y, Takeda A, Fujita Y, Yamazaki Y (2008) Resistin is closely related to systemic inflammation in obstructive sleep apnea. Respiration 76(4):377–385
93. Cherneva RV, Georgiev OB, Petrova DS, Mondeshki TL, Ruseva SR, Cakova AD, Mitev VI (2013) Resistin — the link between adipose tissue dysfunction and insulin resistance in patients with obstructive sleep apnea. J Diabetes Metab Disord 12(1):5
94. Zhang XL, Yin KS, Wang H, Su S (2006) Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 73(1):73–77
95. Zhang XL, Yin KS, Li C, Jia EZ, Li YQ, Gao ZF (2007) Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chin Med J (Engl) 120(17):1477–1481
96. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, Somers VK (2005) Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13(1):186–190
97. Blankenberg S, Rupprecht HJ, Bickel C, Peetz D, Hafner G, Tiret L, Meyer J (2001) Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 104(12):1336–1342
98. Shyu KG, Chang H, Lin CC, Kuan P (1996) Circulating intercellular adhesion molecule-1 and E-selectin in patients with acute coronary syndrome. Chest 109(6):1627–1630
99. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87(1):10–14
100. Chin K, Nakamura T, Shimizu K, Mishima M, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109(7):562–567
101. Varvarigou V, Dahabreh IJ, Malhotra A, Kales SN (2011) A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis. Sleep 34(11):1461–1468
102. Hoffmann MS, Singh P, Wolk R, Romero-Corral A, Raghavakaimal S, Somers VK (2007) Microarray studies of genomic oxidative stress and cell cycle responses in obstructive sleep apnea. Antioxid Redox Signal 9(6):661–669
103. Gozal D, Jortani S, Snow AB, Kheirandish-Gozal L, Bhattacharjee R, Kim J, Capdevila OS (2009) Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 180(12):1253–1261